Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Freenome Inc (FRNM) AI Stock Analysis

17 Followers
FRNM

Freenome Inc

(NASDAQ:FRNM)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Negative Factors

Freenome Inc (FRNM) vs. SPDR S&P 500 ETF (SPY)

-10%0%10%20%30%40%50%60%FRNM-5.21%SPY+9.07%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$85.41M
Dividend Yield
―
Average Volume (3M)
838.24K
Price to Earnings (P/E)
-171.2
Beta (1Y)
0.16
Revenue Growth
―
EPS Growth
-123.69%
Country
US
Employees
378
Sector
Financial
Sector Strength
68
Industry
Medical - Diagnostics & Research

Freenome Inc Business Overview & Revenue Model

Company Description

Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company's proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation pat...

Freenome Inc Risk Analysis

Freenome Inc disclosed 106 risk factors in its most recent earnings report. Freenome Inc reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

1 New Risk
1.Changes in international trade policies, tariffs and treaties affecting imports and exports may adversely affect our ability to consummate an initial Business Combination target or the operations and financial results of a post-Business Combination company.Q1, 2026

Freenome Inc Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

FRNM against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
BSLKBSLK29Underperform$2,1830.0086.44%―――

* Financial Sector Average

Performance Comparison

-50%0%50%FRNMBSLKDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
FRNM and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
FRNMFreenome, Inc.10.18-0.56-5.21%
BSLKBolt Projects Holdings, Inc.0.05-2.19-97.77%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.